Biomedicines (Feb 2022)

Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism?

  • Giovanni Bolcato,
  • Matteo Pavan,
  • Davide Bassani,
  • Mattia Sturlese,
  • Stefano Moro

DOI
https://doi.org/10.3390/biomedicines10020515
Journal volume & issue
Vol. 10, no. 2
p. 515

Abstract

Read online

Adenosine receptors have been a promising class of targets for the development of new therapies for several diseases. In recent years, a renewed interest in this field has risen, thanks to the implementation of a novel class of agonists that lack the ribose moiety, once considered essential for the agonistic profile. Recently, an X-ray crystal structure of the A2A adenosine receptor has been solved, providing insights about the receptor activation from this novel class of agonists. Starting from this structural information, we have performed supervised molecular dynamics (SuMD) simulations to investigate the binding pathway of a non-nucleoside adenosine receptor agonist as well as one of three classic agonists. Furthermore, we analyzed the possible role of water molecules in receptor activation.

Keywords